Get the Facts

Find what you need to know
in our brochures.

DOWNLOAD

Get our
Press Kit

Official information for
articles and stories.

GET PRESS KIT

Multiple Myeloma News

Sort by Category:

Curing myeloma at last: defining criteria and providing the evidence.

Barlogie B, Mitchell A, van Rhee F, Epstein J, Morgan GJ, Crowley J.
Blood. 2014 Nov 13;124(20):3043-51. doi: 10.1182/blood-2014-07-552059. Epub 2014 Oct 7.
PMID: 25293776 [PubMed - in process]
Related citations
Read More

November 25, 2014

A Phase II, Randomized, Double-Blind, Placebo-Controlled Study of Siltuximab (Anti-IL-6 mAb) and Bortezomib versus Bortezomib Alone in Patients with Relapsed or Refractory Multiple Myeloma.

Orlowski RZ, Gercheva L, Williams C, Sutherland H, Robak T, Masszi T, Goranova-Marinova V, Dimopoulos MA, Cavenagh JD, Spička I, Maiolino A, Suvorov A, Bladé J, Samoylova O, Puchalski TA, Reddy M, Bandekar R, van de Velde H, Xie H, Rossi JF.
Am J Hematol. 2014 Oct 8. doi: 10.1002/ajh.23868. [Epub ahead of print]
PMID: 25294016 [PubMed - as supplied by publisher]
Related citations
Read More

November 25, 2014

Early relapse after single auto-SCT for multiple myeloma is a major predictor of survival in the era of novel agents.

Jimenez-Zepeda VH, Reece DE, Trudel S, Chen C, Tiedemann R, Kukreti V.
Bone Marrow Transplant. 2014 Oct 27. doi: 10.1038/bmt.2014.237. [Epub ahead of print]
PMID: 25347006 [PubMed - as supplied by publisher]
Related citations
Read More

November 25, 2014

Page 1 of 2112345...1020...Last »